XML 9 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Assets    
Loans held for investment $ 360,987,934 $ 364,238,847
Loans held for investment - related party (Note 8) 38,467,545 38,238,199
Loans held for investment, at carrying value [1] 399,455,479 402,477,046
Current expected credit loss reserve (3,274,058) (4,346,869)
Loans held for investment at carrying value, net 396,181,421 398,130,177
Loans, at fair value - related party 5,335,000 5,335,000
Cash and cash equivalents 9,879,177 26,400,448
Other receivables and assets, net 525,277 459,187
Interest receivable 1,515,898 1,453,823
Related party receivables 1,228,559 3,370,339
Total Assets 414,665,332 435,148,974
Liabilities    
Revolving loan 38,000,000 55,000,000
Notes payable, net 49,155,713 49,096,250
Dividend payable 9,820,079 13,605,153
Related party payables 1,586,509 2,043,403
Management and incentive fees payable 1,735,533 2,863,158
Accounts payable and other liabilities 2,539,925 2,285,035
Interest reserve 547,526 1,297,878
Payable for investment purchased 500,000  
Total Liabilities 103,885,285 126,190,877
Commitments and contingencies (Note 9)
Stockholders’ equity    
Common stock, par value $0.01 per share, 100,000,000 shares authorized and 20,893,785 and 20,829,228 shares issued and outstanding, respectively 208,938 208,292
Additional paid-in-capital 320,486,840 318,886,768
Accumulated deficit (9,915,731) (10,136,963)
Total stockholders’ equity 310,780,047 308,958,097
Total liabilities and stockholders’ equity $ 414,665,332 $ 435,148,974
[1] Amounts are presented by loan origination year with subsequent advances on delayed draw facilities shown in the initial year of origination.